Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin LymphomasB-cell neoplasm, B-cell non-Hodgkin lymphoma, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingNot stated2025-11-04NCT02633111

5 results · Page 1 of 1

Swipe the table sideways for more columns.

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Mayo ClinicRochesterUnited States68
MD Anderson Cancer CenterHoustonUnited States589
Memorial Sloan Kettering Basking RidgeBasking RidgeUnited States189
Memorial Sloan Kettering BergenMontvaleUnited States193
Memorial Sloan Kettering Cancer CenterHarrisonUnited States3
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Memorial Sloan Kettering CommackCommackUnited States189
Memorial Sloan Kettering MonmouthMiddletownUnited States206
Memorial Sloan Kettering NassauUniondaleUnited States193
Memorial Sloan Kettering WestchesterHarrisonUnited States204
University of MiamiMiamiUnited States6
University of PennsylvaniaPhiladelphiaUnited States4